Lucid Diagnostics Correlations

LUCD Stock  USD 1.21  0.14  13.08%   
The current 90-days correlation between Lucid Diagnostics and Rapid Micro Biosystems is 0.07 (i.e., Significant diversification). The correlation of Lucid Diagnostics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Lucid Diagnostics Correlation With Market

Weak diversification

The correlation between Lucid Diagnostics and DJI is 0.3 (i.e., Weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Lucid Diagnostics and DJI in the same portfolio, assuming nothing else is changed.
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Lucid Diagnostics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as various price indices.
For information on how to trade Lucid Stock refer to our How to Trade Lucid Stock guide.

Moving together with Lucid Stock

  0.73002901 Double Medical TechnologyPairCorr
  0.7TOI Oncology InstitutePairCorr
  0.61HYPR HyperfinePairCorr
  0.75688613 Allgens Medical TechPairCorr
  0.71EYE Nova EYE MedicalPairCorr
  0.67688108 Sino Medical SciencesPairCorr
  0.81OSUR OraSure TechnologiesPairCorr

Moving against Lucid Stock

  0.51300981 Zhonghong Pulin MedicalPairCorr
  0.46688198 Beijing Balance MedicalPairCorr
  0.33301367 BMC MedicalPairCorr
  0.42002950 Allmed Medical ProductsPairCorr

Related Correlations Analysis


Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

SEERSTSS
APYXRPID
SEERRCEL
AVRIRD
STSSRCEL
IXHLOWLT
  

High negative correlations

OWLTSEER
OWLTSTSS
SCLXAVR
IXHLRCEL
SEERAPYX
STSSAPYX

Risk-Adjusted Indicators

There is a big difference between Lucid Stock performing well and Lucid Diagnostics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Lucid Diagnostics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
RPID  4.44  0.50  0.12  0.52  3.88 
 12.73 
 27.30 
APYX  2.98  0.36  0.11  0.38  2.74 
 8.25 
 21.53 
RCEL  2.58  0.17  0.05  0.37  2.45 
 6.67 
 16.25 
IRD  3.27  0.45  0.10  1.79  3.57 
 6.70 
 26.50 
STSS  5.68 (1.18) 0.00 (0.30) 0.00 
 10.45 
 39.53 
AVR  4.24  0.17  0.04  0.20  4.21 
 9.42 
 25.09 
SEER  1.43 (0.25) 0.00 (0.29) 0.00 
 3.41 
 9.98 
OWLT  4.01  0.69  0.14  1.51  4.37 
 9.52 
 30.32 
IXHL  4.08 (0.19) 0.00 (0.02) 0.00 
 11.76 
 26.74 
SCLX  4.72 (0.35) 0.00 (0.09) 0.00 
 10.97 
 28.87 

Lucid Diagnostics Corporate Management

Lishan MDChairman CEOProfile
Joseph MDStrategic CofounderProfile
Deepika LakhaniChief OfficerProfile
Michael GordonGeneral SecretaryProfile
Michael ParksVice RelationsProfile
Adrian MillerVP RelationsProfile
Amitabh MDStrategic CofounderProfile